In line with these findings, we found that FLRT2 upregulation significantly reduced the ability of NSCLC stem cells to form tumor spheres by decreasing the abundance of stemness-related genes, including OTC4, CD44, and CD133. The gene discussed is CD44; the disease is non-small cell lung carcinoma.